- Oops!Something went wrong.Please try again later.
Coca-Cola's sales could recover much more quickly than expected from depressed pandemic levels, Morgan Stanley says.
Management said the relatively weak results are the result of more normal business activity and less remote work, which is hurting the freelance market. This is a short-term hit to Fiverr, and it makes sense the stock is down big given the fact the company has a market cap of $6.3 billion and expects revenue of just $280 million to $288 million this year.
Yahoo Finance's Jared Blikre breaks down Novavax's latest earnings report as well as the company's latest vaccine research.
As the trading day winds to a close here at 3:45 p.m. EDT, shares of Carnival Corporation (NYSE: CCL) stock are up 6.9% over yesterday's close, and rival Norwegian Cruise Line Holdings (NYSE: NCLH) is close behind with a 6.3% gain. Investors in both these cruise line stocks, however, may owe their good fortune to a third: Royal Caribbean (NYSE: RCL). In case you haven't heard, Royal Caribbean reported its fiscal Q2 earnings results yesterday.
Reconnaissance Energy Africa Ltd. (the "Company" or "ReconAfrica") (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) and its joint venture partner NAMCOR (the state oil company of Namibia) are pleased to provide, based on the mud logging report and geochemical analysis, more comprehensive data confirming a working conventional petroleum system. The Company also reports on additional drilling results and plans for the next phase of exploration in the Kavango Basin, NE Namibia and NW Botswana.
Like other biotechs without any revenue, its value proposition to shareholders is contingent on the success of its clinical trials. The company's drug, simufilam, recently completed its phase 2 clinical trials, and the company plans to start phase 3 before the end of 2021. On July 29, Cassava reported a packet of data showing that simufilam improved cognition, slowed the progression of Alzheimer's disease, and elicited positive changes in a smattering of biomarkers.
Shares of Maxar Technologies (NYSE: MAXR) are falling today, down by 9.7% as of of 12:45 p.m. EDT, after the company reported second-quarter results. For fiscal Q2, Maxar posted revenue of $473 million, which represented a 7.7% year-over-year increase that CEO Dan Jablonsky characterized as "solid." Earnings of $0.60 per share were down significantly from the prior-year period's $4.94 in EPS, but only because last year, Maxar sold off its MDA space business, generating a big one-time profit for the company that was impossible to repeat.
Shares of Microvision (NASDAQ: MVIS) were soaring today after the company released its second-quarter results late yesterday. The company reported quarterly revenue of $0.75 million, an increase of 27% from the year-ago quarter and slightly higher than Wall Street's consensus revenue estimate of $0.7 million. "With a large market and significant growth ahead of us, we see great opportunity for further value creation with our focus on strategic sales," Microvision CEO Sumit Sharma said on the company's investor call.
Historically speaking, these two data points wouldn't be considered good, but right now they're positive signs.
Investors in Castor Maritime (NASDAQ: CTRM) haven't had a pleasant past three months, as the stock has dropped almost 50% in that time. For the three months ended June 30, Castor Maritime earned $6.5 million, building on the $1.1 million profit it made in 2021's first quarter.
You should never count your blowout quarters before they hatch, and that seems to fit when it comes to Roku (NASDAQ: ROKU) this week. The pioneer in home streaming posted what seemed to be pretty spectacular numbers after Wednesday's market close.
(Bloomberg) -- President Joe Biden invited what used to be called Detroit’s big three automakers to the White House to promote sales of electric vehicles -- leaving off the guest list the company that sells more than any other: Tesla Inc.“Yeah, seems odd that Tesla wasn’t invited,” Elon Musk, Tesla’s chief executive, said in a tweet.Also left out: Nissan Motor Co., whose Leaf was a pioneer in electric cars, Honda Motor Co., the first Japanese automaker to promise to phase out gasoline-powered ca
What happened? Shares of pot grower Tilray (NASDAQ: TLRY) are up 4.1% to $14.54 apiece as of 10:30 a.m. EDT. On Aug. 4, Tilray's CEO Irwin Simons gave an exclusive interview to cannabis business news outlet New Cannabis Ventures.
Yahoo Finance's Jared Blikre explains why Carvana stock's after hours pop on Thursday afternoon.
Shares of coronavirus vaccine developer Novavax (NASDAQ: NVAX) are up 6.7% to $238.56 apiece as of 10:30 a.m. EDT. On Aug. 4, Novavax announced the European Commission would purchase 100 million doses of its coronavirus vaccine candidate NVX-CoV2373, with an additional option to purchase 100 million doses by the end of 2023. In clinical studies, the vaccine candidate demonstrated 89.7% to 96.4% overall efficacy in immunization, depending on the strain of the coronavirus.
OPKO Health, Inc. (NASDAQ:OPK) a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. Their CEO has been continuously buying shares, and we were curious as to why that might be.
What happened Shares of Intellia Therapeutics (NASDAQ: NTLA) were up 12% at 3:45 p.m. EDT today after the company reported earnings and updated investors on its clinical trials. Image source: Getty Images.
These income stocks, with yields ranging from 2% to as high as 9.1%, can pack a punch for investors' portfolios.
Zillow Group Inc. blew away Wall Street expectations Thursday with strong second-quarter results and a stunning forecast that calls for large growth in its newer home-flipping business and its first $2 billion quarter of sales.
Robinhood (HOOD) shares tanked 27% to close the session at $50.27 after several wild sessions.
Illumina offered a beat-and-raise quarter late Thursday as the genetic sequencing giant helps track Covid variants. But Illumina stock dipped.